"Institute For Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai Announces Upcoming LymeMIND Conference on Lyme Disease and Precision Medicine"
The Institute for Next Generation Healthcare (INGH) at the Icahn School of Medicine at Mount Sinai announced that it will be hosting its third annual conference on Tuesday, October 2, at the New York Academy of Medicine, and Wednesday, October 3, at the New York Academy of Science in New York, New York. The conference is designed to enhance the network of understanding among clinicians and researchers on the front lines of Lyme disease and the patients who have it. “To better treat this disease, it’s of critical importance for researchers to fully consider both the short- and long-term impact on the patient. However, this understanding has been hindered by a disconnect between researchers and the patient experience, as well as a lack of comprehensively analyzed data on the disease, its treatment and potential long-term effects of both,” said Joel Dudley, PhD, director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai and executive vice president for precision health at the Mount Sinai Health System. “The traditional hypothesis-guided approach has made it difficult for researchers to grasp the full complexity of Lyme, and therefore we haven’t been able to rapidly advance treatment options and provide the greater Lyme community with a solution to mitigate and end suffering.”
- Joel Dudley, PhD, Director, Institute for Next Generation Healthcare, Associate Professor, Genetics and Genomic Sciences, Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, Executive Vice President, Precision Health, Mount Sinai Health System